Mesenchymal Stem Cell Therapy for Inflammatory Brain Disease
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammatory brain diseases such as encephalitis, meningitis, and meningoencephalitis often result in significant side effects like brain injury, weight loss, apoptosis, reactive gliosis, and increased inflammatory cytokines, with limited therapeutic options using stem cells.
Innovation Solution
A pharmaceutical composition comprising mesenchymal stem cells, specifically derived from umbilical cord blood and administered directly into the ventricles, which reduces inflammatory responses and side effects by minimizing brain injury, weight loss, apoptosis, and inflammatory cytokines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat inflammatory brain diseases, then the causative organisms are eliminated, but side effects such as acute brain injury, hydrocephalus, hypacusis, and epilepsy occur
Solution Approach 1:
The patent uses stem cells as an intermediary substance to treat inflammatory brain diseases. Instead of directly using antibiotics that cause harm, stem cells are administered to modulate the immune response and reduce inflammation, thereby treating the underlying condition while avoiding the harmful side effects of conventional antibiotic therapy
Solution Approach 2:
The patent converts the harmful inflammatory response into a beneficial therapeutic effect by using stem cells to regulate and control the inflammation. The stem cells transform the harmful inflammatory process into a controlled healing process, reducing damage while maintaining the body's natural defense mechanisms
2Reliability
If conventional treatments are used for inflammatory brain diseases, then the disease symptoms are addressed, but significant side effects such as weight loss, apoptosis, and reactive gliosis occur
Solution Approach 1:
The patent employs stem cells that possess self-regenerative and self-differentiation capabilities. These cells automatically migrate to damaged areas, differentiate into needed cell types, and regulate inflammation without requiring external intervention, thereby treating the disease while minimizing harmful side effects through the body's own healing mechanisms
3Object-affected harmful factors
If stem cells are administered to treat inflammatory brain diseases, then therapeutic effects are achieved with reduced side effects, but systematic studies have been limited so far
Solution Approach 1:
The patent optimizes multiple parameters of stem cell therapy including cell dosage (1×10^6 to 1×10^8 cells), administration route (intravenous, intracerebral, or intraventricular), and timing of administration. By systematically varying these parameters, the patent establishes an effective treatment protocol that maximizes therapeutic benefits while minimizing side effects
Data Source
Figure 1~3
Figure 4~5
Figure 6~7
AI summary
The present invention relates to a composition for treating inflammatory brain diseases which includes a stem cell as an active ingredient. When the stem cell according to the present invention is directly administered to animal models with inflammatory brain diseases, a brain damage caused by inflammation such as edema is significantly reduced, the weight-loss phenomenon is greatly improved, and the like, and thus the cell has an excellent effect in treating inflammatory brain diseases and consequently can be used effectively in treating inflammatory brain diseases.